JPMorgan Chase & Co. Reduces Position in Relay Therapeutics, Inc. $RLAY

JPMorgan Chase and Co. cut its holdings in shares of Relay Therapeutics, Inc. (NASDAQ: RLAY) by 89.3% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 462,379 shares of the company's stock after selling 3,876,024 shares during the period. JPMorgan